[1]
|
Benjamin, M., Toumi, H., Ralphs, J.R., et al. (2006) Where Tendons and Ligaments Meet Bone: Attachment Sites (‘En-theses’) in Relation to Exercise and/or Mechanical Load. Journal of Anatomy, 208, 471-490.
https://doi.org/10.1111/j.1469-7580.2006.00540.x
|
[2]
|
Rossetti, L., Kuntz, L.A., Kunold, E., et al. (2017) The Microstructure and Micromechanics of the Tendon-Bone Insertion. Nature Materials, 16, 664-670. https://doi.org/10.1038/nmat4863
|
[3]
|
Benjamin, M., Moriggl, B., Brenner, E., et al. (2004) The “Enthesis Organ” Concept: Why Enthesopathies May Not Present as Focal Insertional Disorders. Arthritis & Rheumatism, 50, 3306-3313. https://doi.org/10.1002/art.20566
|
[4]
|
Benjamin, M. and McGonagle, D. (2001) The Anatomical Basis for Disease Localisation in Seronegative Spondyloarthropathy at Entheses and Related Sites. Journal of Anatomy, 199, 503-526.
https://doi.org/10.1046/j.1469-7580.2001.19950503.x
|
[5]
|
Schett, G., Lories, R.J., D’Agostino, M., et al. (2017) Enthesitis: From Pathophysiology to Treatment. Nature Reviews Rheumatology, 13, 731-741. https://doi.org/10.1038/nrrheum.2017.188
|
[6]
|
Jacques, P., Lambrecht, S., Verheugen, E., et al. (2014) Proof of Concept: Enthesitis and New Bone Formation in Spondyloarthritis Are Driven by Mechanical Strain and Stromal Cells. Annals of the Rheumatic Diseases, 73, 437-445.
https://doi.org/10.1136/annrheumdis-2013-203643
|
[7]
|
Paulissen, S.M., van Hamburg, J.P., Davelaar, N., et al. (2013) Synovial Fibroblasts Directly Induce Th17 Pathogenicity via the Cyclooxygenase/Prostaglandin E2 Pathway, In-dependent of IL-23. The Journal of Immunology, 191, 1364-1372. https://doi.org/10.4049/jimmunol.1300274
|
[8]
|
Bergqvist, F., Carr, A.J., Wheway, K., et al. (2019) Divergent Roles of Prostacyclin and PGE2 in Human Tendinopathy. Arthritis Research & Therapy, 21, 74. https://doi.org/10.1186/s13075-019-1855-5
|
[9]
|
Gaffen, S.L. (2009) Structure and Signalling in the IL-17 Recep-tor Family. Nature Reviews Rheumatology, 9, 556-567.
https://doi.org/10.1038/nri2586
|
[10]
|
Amatya, N., Garg, A.V. and Gaffen, S.L. (2017) IL-17 Signaling: The Yin and the Yang. Trends in Immunology, 38, 310-322. https://doi.org/10.1016/j.it.2017.01.006
|
[11]
|
Aggarwal, S., Ghilardi, N., Xie, M.H., de Sauvage, F.J. and Gurney, A.L. (2003) Interleukin-23 Promotes a Distinct CD4 T Cell Acti-vation State Characterized by the Production of Interleukin-17. The Journal of Biological Chemistry, 278, 1910-1914. https://doi.org/10.1074/jbc.M207577200
|
[12]
|
Kenna, T.J., Davidson, S.I., Duan, R., et al. (2012) Enrichment of Circulating Interleukin-17-Secreting Interleukin-23 Receptor-Positive Gamma/Delta T Cells in Patients with Active An-kylosing Spondylitis. Arthritis & Rheumatism, 64, 1420-1429. https://doi.org/10.1002/art.33507
|
[13]
|
McGonagle, D.G., McInnes, I.B., Kirkham, B.W., Sherlock, J. and Moots, R. (2019) The Role of IL-17A in Axial Spondyloarthritis and Psoriatic Arthritis: Recent Advances and Controversies. Annals of the Rheumatic Diseases, 78, 1167-1178. https://doi.org/10.1136/annrheumdis-2019-215356
|
[14]
|
Reinhardt, A., Yevsa, T., Worbs, T., et al. (2016) Inter-leukin-23-Dependent Gamma/Delta T Cells Produce Interleukin-17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice. Arthritis & Rheumatology, 68, 2476-2486. https://doi.org/10.1002/art.39732
|
[15]
|
Cuthbert, R.J., Fragkakis, E.M., Dunsmuir, R., et al. (2017) Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis. Ar-thritis & Rheumatology, 69, 1816-1822. https://doi.org/10.1002/art.40150
|
[16]
|
Buonocore, S., Ahern, P.P., Uhlig, H.H., et al. (2010) Innate Lymphoid Cells Drive Interleukin-23-Dependent Innate Intestinal Pathology. Nature, 464, 1371-1375. https://doi.org/10.1038/nature08949
|
[17]
|
Geremia, A., Arancibia-Carcamo, C.V., Fleming, M.P., et al. (2011) IL-23-Responsive Innate Lymphoid Cells Are Increased in Inflammatory Bowel Disease. The Journal of Experi-mental Medicine, 208, 1127-1133.
https://doi.org/10.1084/jem.20101712
|
[18]
|
Bridgewood, C., Watad, A., Russell, T., et al. (2019) Identification of Myeloid Cells in the Human Enthesis as the Main Source of Local IL-23 Production. Annals of the Rheumatic Diseases, 78, 929-933.
https://doi.org/10.1136/annrheumdis-2018-214944
|
[19]
|
Sherlock, J.P., Joyce-Shaikh, B., Turner, S., et al. (2013) Interleukin 23 Is Critical in the Pathogenesis of Spondyloarthropathy and Acts on a Novel Population of Interleukin 23R+ Entheseal Resident Cells. The Lancet, 381, S14.
https://doi.org/10.1016/S0140-6736(13)60454-7
|
[20]
|
Sherlock, J.P., Joyce-Shaikh, B., Turner, S.P., et al. (2012) IL-23 Induces Spondyloarthropathy by Acting on ROR-Gammat+ CD3+CD4−CD8− Entheseal Resident T Cells. Nature Medicine, 18, 1069-1076.
https://doi.org/10.1038/nm.2817
|
[21]
|
Brown, M.A., Kenna, T. and Wordsworth, B.P. (2016) Genetics of Anky-losing Spondylitis—Insights into Pathogenesis. Nature Reviews Rheumatology, 12, 81-91. https://doi.org/10.1038/nrrheum.2015.133
|
[22]
|
Siebert, S., Millar, N.L. and McInnes, I.B. (2019) Why Did IL-23p19 Inhibition Fail in AS: A Tale of Tissues, Trials or Translation? Annals of the Rheumatic Diseases, 78, 1015-1018. https://doi.org/10.1136/annrheumdis-2018-213654
|
[23]
|
van Tok, M.N., Na, S., Lao, C.R., et al. (2018) The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling. Frontiers in Immunology, 9, 1550.
https://doi.org/10.3389/fimmu.2018.01550
|
[24]
|
Loi, F., Cordova, L.A., Pajarinen, J., et al. (2016) Inflammation, Fracture and Bone Repair. Bone, 86, 119-130.
https://doi.org/10.1016/j.bone.2016.02.020
|
[25]
|
Olsen, B.R., Reginato, A.M. and Wang, W. (2000) Bone Devel-opment. Annual Review of Cell and Developmental Biology, 16, 191-220. https://doi.org/10.1146/annurev.cellbio.16.1.191
|
[26]
|
Wozney, J.M. (1998) The Bone Morphogenetic Protein Family: Multifunctional Cellular Regulators in the Embryo and Adult. European Journal of Oral Sciences, 106, 160-166. https://doi.org/10.1111/j.1600-0722.1998.tb02170.x
|
[27]
|
Waite, K.A. and Eng, C. (2003) From Developmental Disorder to Heritable Cancer: It’s All in the BMP/TGF-Beta Family. Nature Reviews Genetics, 4, 763-773. https://doi.org/10.1038/nrg1178
|
[28]
|
Lories, R.J., Daans, M., Derese, I., et al. (2006) Noggin Haploinsufficiency Differentially Affects Tissue Responses in Destructive and Remodeling Arthritis. Arthritis & Rheumatism, 54, 1736-1746. https://doi.org/10.1002/art.21897
|
[29]
|
Lories, R.J., Derese, I. and Luyten, F.P. (2005) Modulation of Bone Morphogenetic Protein Signaling Inhibits the Onset and Progression of Ankylosing Enthesitis. Journal of Clinical Investigation, 115, 1571-1579.
https://doi.org/10.1172/JCI23738
|
[30]
|
Rauner, M., Baschant, U., Roetto, A., et al. (2019) Transferrin Receptor 2 Controls Bone Mass and Pathological Bone Formation via BMP and Wnt Signaling. Nature Metabolism, 1, 111-124. https://doi.org/10.1038/s42255-018-0005-8
|
[31]
|
Bennett, C.N., Ouyang, H., Ma, Y.L., et al. (2007) Wnt10b In-creases Postnatal Bone Formation by Enhancing Osteoblast Differentiation. Journal of Bone and Mineral Research, 22, 1924-1932. https://doi.org/10.1359/jbmr.070810
|
[32]
|
Moon, R.T., Kohn, A.D., De Ferrari, G.V. and Kaykas, A. (2004) WNT and Beta-Catenin Signalling: Diseases and Therapies. Nature Reviews Genetics, 5, 691-701. https://doi.org/10.1038/nrg1427
|
[33]
|
Piters, E., Boudin, E. and Van Hul, W. (2008) WNT Signaling: A Win for Bone. Archives of Biochemistry and Biophysics, 473, 112-116. https://doi.org/10.1016/j.abb.2008.03.006
|
[34]
|
Day, T.F., Guo, X., Garrett-Beal, L., et al. (2005) WNT/Beta-Catenin Signaling in Mesenchymal Progenitors Controls Osteo-blast and Chondrocyte Differentiation during Vertebrate Skeletogenesis. Developmental Cell, 8, 739-750.
https://doi.org/10.1016/j.devcel.2005.03.016
|
[35]
|
Kawano, Y. and Kypta, R. (2000) Secreted Antagonists of the WNT Signalling Pathway. Journal of Cell Science, 116, 2627-2634. https://doi.org/10.1242/jcs.00623
|
[36]
|
Li, X., Liu, P., Liu, W., et al. (2005) Dkk2 Has a Role in Terminal Osteoblast Differentiation and Mineralized Matrix Formation. Nature Genetics, 37, 945-952. https://doi.org/10.1038/ng1614
|
[37]
|
Haynes, K.R., Pettit, A.R., Duan, R., et al. (2012) Excessive Bone Formation in a Mouse Model of Ankylosing Spondylitis Is Associated with Decreases in WNT Pathway Inhibitors. Arthritis Research & Therapy, 14, R253.
https://doi.org/10.1186/ar4096
|
[38]
|
Heiland, G.R., Appel, H., Poddubnyy, D., et al. (2012) High Level of Func-tional Dickkopf-1 Predicts Protection from syNdesmophyte Formation in Patients with Ankylosing Spondylitis. Annals of the Rheumatic Diseases, 71, 572-574.
https://doi.org/10.1136/annrheumdis-2011-200216
|
[39]
|
Yang, J., Andre, P., Ye, L. and Yang, Y.-Z. (2015) The Hedgehog Signalling Pathway in Bone Formation. International Journal of Oral Science, 7, 73-79. https://doi.org/10.1038/ijos.2015.14
|
[40]
|
Ruiz-Heiland, G., Horn, A., Zerr, P., et al. (2012) Blockade of the Hedgehog Pathway Inhibits Osteophyte Formation in Arthritis. Annals of the Rheumatic Diseases, 71, 400-407. https://doi.org/10.1136/ard.2010.148262
|
[41]
|
Dittmann, K., Wuelling, M., Uhmann, A., et al. (2014) Inactivation of Patched1 in Murine Chondrocytes Causes Spinal Fusion without Inflammation. Arthritis & Rheumatology, 66, 831-840. https://doi.org/10.1002/art.38325
|
[42]
|
Daoussis, D., Filippopoulou, A., Liossis, S.N., et al. (2015) An-ti-TNFalpha Treatment Decreases the Previously Increased Serum Indian Hedgehog Levels in Patients with Ankylosing Spondylitis and Affects the Expression of Functional Hedgehog Pathway Target Genes. Seminars in Arthritis and Rheumatism, 44, 646-651.
https://doi.org/10.1016/j.semarthrit.2015.01.004
|
[43]
|
Chen, X., Macica, C., Nasiri, A., Judex, S. and Broadus, A.E. (2007) Mechanical Regulation of PTHrP Expression in Entheses. Bone, 41, 752-759. https://doi.org/10.1016/j.bone.2007.07.020
|
[44]
|
Han, X., Guo, L., Wang, F., Zhu, Q.S. and Yang, L. (2014) Con-tribution of PTHrP to Mechanical Strain-Induced Fibrochondrogenic Differentiation in Entheses of Achilles Tendon of Miniature Pigs. Journal of Biomechanics, 47, 2406-2414. https://doi.org/10.1016/j.jbiomech.2014.04.022
|
[45]
|
Han, X., Zhuang, Y., Zhang, Z., Guo, L. and Wang, W. (2016) Regulatory Mechanisms of the Ihh/PTHrP Signaling Pathway in Fibrochondrocytes in Entheses of Pig Achilles Tendon. Stem Cells International, 2016, Article ID: 8235172. https://doi.org/10.1155/2016/8235172
|
[46]
|
Mouterde, G., Aegerter, P., Correas, J.M., et al. (2014) Value of Contrast-Enhanced Ultrasonography for the Detection and Quantifica-tion of Enthesitis Vascularization in Patients with Spondyloarthritis. Arthritis Care & Research, 66, 131-138. https://doi.org/10.1002/acr.22195
|
[47]
|
Hakeda, Y., Nakatani, Y., Kurihara, N., et al. (1985) Prostaglandin E2 Stimulates Collagen and Non-Collagen Protein Synthesis and Prolyl Hydroxylase Activity in Osteoblastic Clone MC3T3-E1 Cells. Biochemical and Biophysical Research Communications, 126, 340-345. https://doi.org/10.1016/0006-291X(85)90611-4
|
[48]
|
Lie, E., Kristensen, L.E., Forsblad-d’Elia, H., et al. (2015)The Effect of Comedication with Conventional Synthetic Disease Modifying Antirheumatic Drugs on TNF Inhib-itor Drug Survival in Patients with Ankylosing Spondylitis and Undifferentiated Spondyloarthritis: Results from a Na-tionwide Prospective Study. Annals of the Rheumatic Diseases, 74, 970-978. https://doi.org/10.1136/annrheumdis-2014-206616
|
[49]
|
Gladman, D.D., Kavanaugh, A., Gomez-Reino, J.J., et al. (2018) Therapeutic Benefit of Apremilast on Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: A Pooled Anal-ysis of the PALACE 1-3 Studies. RMD Open, 4, e669.
https://doi.org/10.1136/rmdopen-2018-000669
|
[50]
|
Marzo-Ortega, H., McGonagle, D., Jarrett, S., et al. (2005) Infliximab in Combination with Methotrexate in Active Ankylosing Spondylitis: A Clinical and Imaging Study. Annals of the Rheumatic Diseases, 64, 1568-1575.
https://doi.org/10.1136/ard.2004.022582
|
[51]
|
McInnes, I.B., Kavanaugh, A., Gottlieb, A.B., et al. (2013) Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 1 Year Results of the Phase 3, Multicentre, Dou-ble-Blind, Placebo-Controlled PSUMMIT 1 Trial. The Lancet, 382, 780-789. https://doi.org/10.1016/S0140-6736(13)60594-2
|
[52]
|
Dubash, S., Bridgewood, C., McGonagle, D. and Mar-zo-Ortega, H. (2019) The Advent of IL-17A Blockade in Ankylosing Spondylitis: Secukinumab, Ixekizumab and Be-yond. Expert Review of Clinical Immunology, 15, 123-134.
https://doi.org/10.1080/1744666X.2019.1561281
|